-
Reporting season quick takes
Roger Montgomery
August 30, 2024
Amid a hectic reporting week, we offer the following quick takes, highlighting the results of key, high-quality companies. Continue…
by Roger Montgomery Posted in Companies, Stocks We Like.
- save this article
- POSTED IN Companies, Stocks We Like.
-
Have global carmakers sown the seeds of their own destruction in China?
Roger Montgomery
August 26, 2024
Reggae legend Bob Marley might have been channelling the Bible when he wrote the lyrics for Zion Train and famously observed, “Don’t gain the world and lose your soul; wisdom is better than silver or gold”.
Warren Buffett once famously noted, “We’ve never succeeded in making a good deal with a bad person.” Continue…
by Roger Montgomery Posted in Economics.
- 3 Comments
- save this article
- 3
- POSTED IN Economics.
-
Investor Mark Spitznagel predicts a bursting market bubble, is he right?
Roger Montgomery
July 24, 2024
Doom-and-gloomers, of which there are many, are the Henny Pennys of the financial world; those who constantly fear the sky will fall in, so warn others of its imminent inevitability. Are there any worth listening to? Perhaps we have found one. Continue…
by Roger Montgomery Posted in Companies, Editor's Pick, Market commentary.
- 2 Comments
- save this article
- 2
- POSTED IN Companies, Editor's Pick, Market commentary.
-
WHITEPAPERS
Investing in the Next Phase of Artificial Intelligence
Polen Capital
July 3, 2024
In recent years, very few developments have captured investors’ imagination and curiosity as much as the emergence of generative artificial intelligence (AI). Explore the transformative impact of AI and the investment opportunities it presents across various sectors globally in Polen Capital’s latest whitepaper. Continue…
by Polen Capital Posted in Technology & Telecommunications, Whitepapers.
-
ResMed delivers solid FY24 results
Roger Montgomery
August 5, 2024
ResMed (ASX:RMD) reported its June quarter and full year results after the U.S. market closed on Friday morning. The company met consensus expectations for both revenue and earnings.
ResMed’s revenue rose nine per cent to US$1.2 billion ($1.85 billion) in the last quarter of fiscal 2024, taking quarterly dividends to US$0.53 per share, up 10 per cent. Operating profit was up 38 per cent, and non-GAAP operating profit was up 30 per cent. Continue…
by Roger Montgomery Posted in Companies, Editor's Pick, Stocks We Like.
- save this article
- POSTED IN Companies, Editor's Pick, Stocks We Like.
-
CSL posts strong sales and profit growth
Roger Montgomery
August 19, 2024
Australian Securities Exchange (ASX) healthcare leader CSL (ASX:CSL) posted a robust 11 per cent rise in sales from US$13.3 billion to US$14.8 billion, with CSL’s Behring segment, that markets products like immunoglobulin derived from blood plasma, contributing over 70 per cent of total sales. The company also reported a 21.8 per cent increase in earnings before interest, tax, depreciation and amortisation (EBITDA), a 24 per cent rise in earnings before interest and taxes (EBIT) and a 15 per cent growth in net profit for 2024, after adjusting for currency fluctuations. Continue…
by Roger Montgomery Posted in Companies, Stocks We Like.
- save this article
- POSTED IN Companies, Stocks We Like.
-
Seven global companies with bright prospects
Roger Montgomery
June 26, 2024
Since the beginning of the year, the Polen Capital Global Growth Fund has traded, or adjusted positions in, a number of portfolio holdings and as some of the names are those you are likely familiar with, Polen Capital thought it would be more than a little interesting to shed some light on the reason for the changes. Continue…
by Roger Montgomery Posted in Companies, Polen Capital.
- save this article
- POSTED IN Companies, Polen Capital.
-
Pro Medicus: A decade of exceptional growth and sustained performance
Roger Montgomery
August 20, 2024
Ten years ago, radiology software company Pro Medicus (ASX:PME) was trading at just 86 cents. Yesterday, with a share price of $149, investors have seen their money grow over 17,000 per cent in a decade.
The company supplies software technology used by radiologists (who are extremely expensive for hospitals to employ) for medical diagnoses, which also renders them more efficient. Continue…
by Roger Montgomery Posted in Companies, Editor's Pick.
- save this article
- POSTED IN Companies, Editor's Pick.
-
Can the Commonwealth Bank of Australia’s share price rally continue into FY25?
Roger Montgomery
August 16, 2024
Our domestic large-cap funds have maintained an underweight position in the banks, and even though the Commonwealth Bank of Australia (ASX:CBA) was, for a time, our largest position, being underweight in the sector has cost relative performance thanks to the Commonwealth Bank of Australia’s share price rallying as much as 23 per cent year-to-date and 35 per cent last financial year. Continue…
by Roger Montgomery Posted in Companies.
- save this article
- POSTED IN Companies.
-
Artificial Intelligence and the increasing demand for electricity
David Buckland
July 5, 2024
In this week’s video insight, I discuss the significant impact of artificial intelligence (AI) on companies, particularly the “Magnificent Seven.” AI is driving up the power needs of data centres, far beyond traditional levels. I explain this with the concept of rack power density and highlight predictions about U.S. data centre electricity use. I also mention Amazon Web Services’ recent energy deals and how these changes might influence Australia’s energy policies, including the debate on nuclear power. Continue…
by David Buckland Posted in Technology & Telecommunications, Video Insights.
Watch my latest video insight on why private credit is the smart choiceWATCH HERE